BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32912404)

  • 1. [Clinical characteristics of liver damage in 30 patients with severe coronavirus disease 2019 in Sichuan area].
    Li T; Deng C; Du Q; Yue R; Lu S; Chen H; Guo Y; Huang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):928-932. PubMed ID: 32912404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and treatment of COVID-19 patients in northeast Chongqing.
    Wan S; Xiang Y; Fang W; Zheng Y; Li B; Hu Y; Lang C; Huang D; Sun Q; Xiong Y; Huang X; Lv J; Luo Y; Shen L; Yang H; Huang G; Yang R
    J Med Virol; 2020 Jul; 92(7):797-806. PubMed ID: 32198776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features of COVID-19-Related Liver Functional Abnormality.
    Fan Z; Chen L; Li J; Cheng X; Yang J; Tian C; Zhang Y; Huang S; Liu Z; Cheng J
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1561-1566. PubMed ID: 32283325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
    Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
    Zhang H; Liao YS; Gong J; Liu J; Zhang H
    World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study.
    Chen S; Liu H; Li T; Huang R; Gui R; Zhang J
    Ups J Med Sci; 2020 Nov; 125(4):293-296. PubMed ID: 32990149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
    Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
    Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of coronavirus disease 2019 patients complicated with liver injury.
    Wen M; Lu J; Xie Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):555-559. PubMed ID: 32879106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.
    Wang Q; Zhao H; Liu LG; Wang YB; Zhang T; Li MH; Xu YL; Gao GJ; Xiong HF; Fan Y; Cao Y; Ding R; Wang JJ; Cheng C; Xie W
    Mil Med Res; 2020 Jun; 7(1):28. PubMed ID: 32507110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral kinetics and factors associated with rapid viral clearance during lopinavir/ritonavir-based combination therapy in non-severe COVID-19 patients.
    Ding JG; Li J; Hong L; Yu XQ; Ye EL; Sun GQ; Zhang XX; Chen L; Sun QF
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5788-5796. PubMed ID: 32495917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy and safety of different antiviral regimens in patients with coronavirus disease 2019].
    Gao X; Ma C; Ma Y; Wang X; Wei J; Feng T; Zhao G; Xu L; Zhou W; Zheng X; Zhao Q; Cao X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1423-1427. PubMed ID: 33541491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.
    Huang Q; Deng X; Li Y; Sun X; Chen Q; Xie M; Liu S; Qu H; Liu S; Wang L; He G; Gong Z
    Int J Clin Pharm; 2020 Jun; 42(3):837-845. PubMed ID: 32410206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].
    Liu C; Jiang ZC; Shao CX; Zhang HG; Yue HM; Chen ZH; Ma BY; Liu WY; Huang HH; Yang J; Wang Y; Liu HY; Xu D; Wang JT; Yang JY; Pan HQ; Zou SQ; Li FJ; Lei JQ; Li X; He Q; Gu Y; Qi XL
    Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):107-111. PubMed ID: 32077660
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019.
    Ye XT; Luo YL; Xia SC; Sun QF; Ding JG; Zhou Y; Chen W; Wang XF; Zhang WW; Du WJ; Ruan ZW; Hong L
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3390-3396. PubMed ID: 32271456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Analysis of 25 COVID-19 Infections in Children.
    Bai K; Liu W; Liu C; Fu Y; Hu J; Qin Y; Zhang Q; Chen H; Xu F; Li C
    Pediatr Infect Dis J; 2020 Jul; 39(7):e100-e103. PubMed ID: 32520888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: A retrospective, multi-center study.
    Wang J; Zhu L; Xue L; Liu L; Yan X; Yan X; Huang S; Zhang B; Xu T; Li C; Ji F; Ming F; Zhao Y; Cheng J; Shao H; Chen K; Zhao XA; Sang D; Zhao H; Guan X; Chen X; Chen Y; Liu J; Huang R; Zhu C; Wu C
    J Med Virol; 2021 Jun; 93(6):3305-3311. PubMed ID: 33174624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs.
    Song J; Kang S; Choi SW; Seo KW; Lee S; So MW; Lim DH
    Rheumatol Int; 2020 Jun; 40(6):991-995. PubMed ID: 32314010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief Report: Retrospective Evaluation on the Efficacy of Lopinavir/Ritonavir and Chloroquine to Treat Nonsevere COVID-19 Patients.
    Gao G; Wang A; Wang S; Qian F; Chen M; Yu F; Zhang J; Wang X; Ma X; Zhao T; Zhang F; Chen Z
    J Acquir Immune Defic Syndr; 2020 Oct; 85(2):239-243. PubMed ID: 32740371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.